OMER → $33.00 by Aug 30, 2026.

Ladies and Gents, I present to you the OMER play..... For those who missed the CRSR boat. A heavily beaten down stock with a 800m market cap and a new FDA approved drug, the only kind in the market. Soon to be approved in the European market. Already has a deal in place with Novo Nordisk valued at 2.1 billion. With a low trading volume, a price target of $33 and a short float of 23%..... The only way is …